LICENSE AND SUBLlCENSE AGREEMENTLicense and Subllcense Agreement • November 10th, 2021 • OKYO Pharma LTD • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledNovember 10th, 2021 Company Industry JurisdictionThis License and Sublicense Agreement (“Agreement”) is made effective as of May 22, 2017 (“Effective Date”) by and between on the one hand On Target Therapeutics, LLC, 1S Wynnewood Road, Wellesley, MA 02481 (“On Target” or ‘‘Licensor’’), and Biovitas Capital, 18 South Street, Mayfair, London, W1K 1DG, UK (“Licensee”). Licensor and Licensee are each hereafter referred to individually as a “Party” and together as the “Parties.”